Dr. Dalbagni – who cares for patients with bladder cancer, kidney cancer, penile cancer, and sarcomas – explains treatments offered at Memorial Sloan-Kettering, which can help patients maintain their quality of life.

Our doctors introduce and apply advanced technologies in minimal-access surgery to benefit patients.

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.

Results of an international study indicate that the investigational drug tivozanib is more effective and better tolerated than a currently approved therapy in delaying cancer growth.

March is Kidney Cancer Awareness Month. Watch the latest videos of our kidney cancer experts discussing advances in diagnosis and personalized treatment at our CancerSmart lecture series.